Professor Hywel Williams, Director of the Centre for Evidence Based Dermatology at The University of Nottingham, has been appointed as the new chair of the National Institute of Health Research Health Technology Assessment (NIHR HTA) programme Commissioning Board — which considers the scientific merit of research applications to promote health, prevent and treat disease and improve rehabilitation and long term care.
Hywel Williams, Foundation Professor of Dermato-Epidemiology, will also serve as Deputy Director of the HTA programme which is the largest funder of clinical trials in the UK with an annual budget of £80m.
Professor Williams said: “I have worked as a member of the HTA Commissioning Board for the last four years, and although it has been hard work at times, I have enjoyed every minute of it. Chairing the Board will take me to another level of responsibility, but I will be supported by a superb team and a great mentor in the outgoing chair, Jon Nicholl. I am looking forward to playing my part in making the NHS the best place in the world for research that matters to patients.”
The HTA programme, part of the National Institute for Health Research, commissions research to meet the urgent needs of national NHS decision-making bodies and policy customers, providing the scientific evidence to inform their decisions. It aims to provide reliable and relevant information to help inform decisions on health policy, clinical practice and the management of services.
Professor Tom Walley CBE, Director of the HTA programme said: “I am delighted to announce Professor Hywel William’s appointment. He has a valuable wealth of experience and knowledge which he can bring to these roles.”
Set up in 1993 the HTA programme has become a world leader in the production of independent research information about the effectiveness, costs and broader impact of healthcare treatments and tests for those who use, manage and provide care in the NHS.
The HTA Commissioning Board meets four times a year to assess proposals received in response to advertised and prioritised research topics. The Board considers the scientific merit of the proposals received, before making funding recommendations to the HTA Prioritisation Strategy Group.
More information about the HTA programme and Professor William’s appointment can be found at: www.hta.ac.uk/about and www.hta.ac.uk/news
— Ends —
Notes to editors: The University of Nottingham is ranked in the UK's Top 10 and the World's Top 100 universities by the Shanghai Jiao Tong (SJTU) and Times Higher (THE) World University Rankings.
More than 90 per cent of research at The University of Nottingham is of international quality, according to RAE 2008, with almost 60 per cent of all research defined as ‘world-leading’ or ‘internationally excellent’. Research Fortnight analysis of RAE 2008 ranks the University 7th in the UK by research power. In 27 subject areas, the University features in the UK Top Ten, with 14 of those in the Top Five.
The University provides innovative and top quality teaching, undertakes world-changing research, and attracts talented staff and students from 150 nations. Described by The Times as Britain's “only truly global university”, it has invested continuously in award-winning campuses in the United Kingdom, China and Malaysia. Twice since 2003 its research and teaching academics have won Nobel Prizes. The University has won the Queen's Award for Enterprise in both 2006 (International Trade) and 2007 (Innovation — School of Pharmacy), and was named ‘Entrepreneurial University of the Year’ at the Times Higher Education Awards 2008.
Nottingham was designated as a Science City in 2005 in recognition of its rich scientific heritage, industrial base and role as a leading research centre. Nottingham has since embarked on a wide range of business, property, knowledge transfer and educational initiatives (www.science-city.co.uk) in order to build on its growing reputation as an international centre of scientific excellence. The University of Nottingham is a partner in Nottingham: the Science City.